Smoking cessation for the secondary prevention of coronary heart disease
Sübutlu məlumatların xülasələri
14.07.2017 • Sonuncu dəyişiklik 14.07.2017
Editors
Smoking cessation may be effective in reducing mortality from ischaemic heart disease as well as non-fatal myocardial infarctions by more than 30%.
A Cochrane review (abstract , review ) [withdrawn from publication] included 20 observational studies. There was a 36% reduction in crude relative risk (RR) of mortality for those who quit smoking compared with those who continued to smoke (RR 0.64, 95% confidence interval 0.58 to 0.71). There was also a reduction in non-fatal myocardial infarctions (crude RR 0.68, 95% confidence interval 0.57 to 0.82).
The following decision support rules contain links to this evidence summary:
- Smoking cessation for secondary prevention in atherosclerotic disease
Ədəbiyyat
- Critchley JA, Capewell S. WITHDRAWN: Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2012;(2):CD003041.